首页> 外文期刊>European Journal of Radiology >Analysis of periinterventional complications of intracranial angioplasty and stenting: A single center experience
【24h】

Analysis of periinterventional complications of intracranial angioplasty and stenting: A single center experience

机译:颅内血管成形术和支架置入术的围手术期并发症分析:单中心经验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and purpose Treatment of symptomatic intracranial atherosclerotic disease by angioplasty and stenting (PTAS) is limited by a high rate of periinterventional strokes. We performed a detailed analysis of these strokes at our center in order to identify strategies to reduce the risk of periinterventional complications.Methods Case records and imaging data of 80 patients with a symptomatic 70-99% stenosis of a major intracranial artery treated with PTAS between July 2007 and December 2013 were reviewed. All patients had a sufficient response to aspirin and clopidogrel. Periinterventional strokes were categorized as either ischemic (perforator territory, distal embolic or delayed stent thrombosis) or hemorrhagic (intraparenchymal, subarachnoid).Results Periinterventional complications occurred in 6/80 (7.5%) patients, consisting of 2 ischemic strokes (2.5%, both perforator territory), 3 hemorrhagic strokes (3.8%, 2 intraparenchymal due to reperfusion injury, 1 subarachnoid due to vessel rupture) and one death (1.3%) unrelated to stroke. All strokes occurred within 24 h after PTAS.Conclusion Our retrospective data analysis suggests that the risk of periinterventional stroke after PTAS of symptomatic intracranial atherosclerotic disease might be reduced by sufficient antiplatelet therapy and optimized management of patients with high risk for reperfusion injury or perforator strokes, including selection of a stenting device adapted to individual vessel morphology.
机译:背景和目的血管成形术和支架置入术(PTAS)对有症状的颅内动脉粥样硬化性疾病的治疗受到围手术期中风的高发生率的限制。我们在中心对这些卒中进行了详细的分析,以确定降低围手术期并发症风险的方法。方法病例记录和影像学数据:80例经PTAS治疗的主要颅内动脉狭窄症状为70-99%的患者回顾了2007年7月和2013年12月。所有患者对阿司匹林和氯吡格雷有足够的反应。围手术期卒中分为缺血性(穿支区,远端栓塞或支架内血栓形成)或出血性(实质内,蛛网膜下腔)。结果围手术期并发症发生在6/80(7.5%)患者中,包括2次缺血性卒中(占2.5%,两者均穿孔器区域),3例出血性中风(3.8%,2例因再灌注损伤的实质内,1例由于血管破裂的蛛网膜下腔出血)和1例与中风无关的死亡(1.3%)。所有卒中均发生在PTAS后24小时之内。结论我们的回顾性数据分析表明,通过充分的抗血小板治疗和对再灌注损伤或穿孔性中风的高风险患者进行优化管理,可以降低有症状的颅内动脉粥样硬化性疾病的PTAS后介入性卒中的风险,包括选择适合各个血管形态的支架植入装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号